FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board compr ...

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William "Bill" J. Valle to its Board of Directors, effective April 19, 2024. "On behalf of the Board, I am honored to be officially welcoming Bill," said Stephen "Fred" Divers, MD, AON's chief medical officer and vice chairman of the Board. "Bill has extensive experience and knowledge that wil ...

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce the appointment of William “Bill” J. Valle to its Board of Directors, effective April 19, 2024. “On behalf of the Board, I am honored to be officially welcoming Bill,” said Stephen “Fred” Divers, MD, AON’s chief medical officer and vice chairman of the Board. “Bill has extensive experience and knowledge that wi ...

American Oncology Network, Inc. (NASDAQ:AONC) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants David Gould - Chief Financial Officer Todd Schonherz - Chief Executive Officer Conference Call Participants Operator Good morning and welcome to the American Oncology Network's First Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A. At this time I'd like to turn the conference over to David Gould, Chief Fi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorporat ...

Exhibit 99.1 American Oncology Network, Inc. Announces First Quarter 2024 Financial Results First Quarter 2024 Highlights • Revenue of $364.3 million increased by 20.0% compared to the prior year quarter o Patient encounter growth of 7.1% as compared to the prior year quarter • Added 17 new providers to the AON platform o Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 – American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-le ...

FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing community oncology networks, and the AON Central Lab are pleased to announce the implementation of the new cytogenetics A.I. software HiBand v8.4 for karyogram segmentation and classification. AON Central Lab is the first laboratory in the world to utilize this technology.   Cytogenetics A.I. leverages machine learning to screen chromosomes and genetic disorders in real time ...

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, d ...

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, ...

Company Leadership Change - American Oncology Network (AON) announced that Dave Gould will step down as Chief Financial Officer effective May 17, 2024, to pursue other opportunities [1] - David Afshar has been appointed as the interim Chief Financial Officer effective May 20, 2024, and AON is in the process of finding a new CFO [1] Executive Experience - David Afshar brings over 25 years of experience in healthcare services, having served as CFO for companies with revenues ranging from $300 million to over $1.8 billion [2] - Afshar has experience in both private equity-backed and public company environments, with a strong understanding of stakeholder needs [2] Company Mission and Growth - AON's focus remains on providing best-in-class cancer care to patients in local communities, with confidence in its strategic plans and growth opportunities [3] - AON is committed to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary care [4] Company Overview - Founded in 2018, AON represents more than 240 providers across 21 states, pioneering innovative healthcare solutions through a physician-led model [4] - The company aims to improve patient outcomes while reducing costs and expanding access to quality care, equipping physicians with necessary tools and support [4]